Melittin-Mil-2 Fusion Protein as a Candidate for Cancer Immunotherapy

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-016-0910-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy